RECOMBINANT BOTULINUM VACCINE A/B
1 clinical trials · Condition
◉ Watch RECOMBINANT BOTULINUM VACCINE A/B
| Record | Firm | Date |
|---|---|---|
| Study to Evaluate the Safety, Tolerability and Immunogenicity of Recombinant Botulinum Vaccine A/B in Healthy Adults (NCT00098098) | DynPort Vaccine Company LLC, A GDIT Company | 2004-08-01 |
Track RECOMBINANT BOTULINUM VACCINE A/B automatically
Every clearance here is in the API, with alerts when new ones post.